
Affimed N.V. AFMD
Quartalsbericht 2022-Q2
hinzugefügt 11.08.2022
Affimed N.V. Langfristiger Schuldenstrom 2011-2026 | AFMD
Langfristiger Schuldenstrom Jährlich Affimed N.V.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 492 K | 532 K | - | - | - | - | - | - | - | - |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 532 K | 492 K | 512 K |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M | ||
|
Acer Therapeutics
ACER
|
104 K | - | 2.71 % | $ 14 M | ||
|
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K | ||
|
ADMA Biologics
ADMA
|
1.1 M | $ 16.45 | 0.43 % | $ 3.92 B | ||
|
AgeX Therapeutics
AGE
|
428 K | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | ||
|
AbCellera Biologics
ABCL
|
5.82 M | $ 3.64 | -1.89 % | $ 1.09 B | ||
|
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | ||
|
Aptorum Group Limited
APM
|
433 K | $ 0.83 | 4.23 % | $ 4.53 M | ||
|
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | ||
|
Alpine Immune Sciences
ALPN
|
756 K | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
10.8 M | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
274 K | - | -11.43 % | $ 502 K | ||
|
ANI Pharmaceuticals
ANIP
|
1.8 M | $ 76.75 | 0.85 % | $ 1.48 B | ||
|
Apellis Pharmaceuticals
APLS
|
7.09 M | $ 19.93 | -1.14 % | $ 2.51 B | ||
|
Applied Therapeutics
APLT
|
429 K | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
2.2 M | - | -13.39 % | $ 1.45 M | ||
|
Adverum Biotechnologies
ADVM
|
5.67 M | - | - | $ 86.2 M | ||
|
Athersys
ATHX
|
1.01 M | - | 3.77 % | $ 22.4 M | ||
|
ARCA biopharma
ABIO
|
213 K | - | 1052.0 % | $ 415 M | ||
|
AVEO Pharmaceuticals
AVEO
|
11 K | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
434 K | $ 163.82 | -0.14 % | $ 8.15 B | ||
|
BridgeBio Pharma
BBIO
|
6.19 M | $ 66.98 | 3.8 % | $ 12.8 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
549 K | - | -2.5 % | $ 5.88 M | ||
|
Acasti Pharma
ACST
|
75 K | - | 4.01 % | $ 150 M | ||
|
BeiGene, Ltd.
BGNE
|
20.7 M | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
11 M | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
3.29 M | - | -7.31 % | $ 87 M | ||
|
CureVac N.V.
CVAC
|
3.47 M | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M | ||
|
Bellerophon Therapeutics
BLPH
|
203 K | - | -74.18 % | $ 955 K | ||
|
BioLineRx Ltd.
BLRX
|
522 K | $ 2.88 | 2.51 % | $ 908 M | ||
|
BioMarin Pharmaceutical
BMRN
|
8.57 M | $ 60.75 | 3.79 % | $ 11.7 B | ||
|
AIkido Pharma
AIKI
|
410 K | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
2.59 M | $ 3.24 | 1.73 % | $ 1.16 M | ||
|
Cabaletta Bio
CABA
|
3.56 M | $ 3.41 | 4.77 % | $ 3.98 M | ||
|
Ayala Pharmaceuticals
AYLA
|
419 K | - | - | $ 7.46 M | ||
|
Capricor Therapeutics
CAPR
|
749 K | $ 25.71 | -0.5 % | $ 688 M | ||
|
Agios Pharmaceuticals
AGIO
|
18.4 M | $ 28.49 | 0.04 % | $ 1.65 B | ||
|
CymaBay Therapeutics
CBAY
|
7 K | - | - | $ 3.45 B | ||
|
Avid Bioservices
CDMO
|
1.35 M | - | - | $ 789 M |